{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2018:6EP3YRVP6COXGB32DT6ZOXTAIK","short_pith_number":"pith:6EP3YRVP","schema_version":"1.0","canonical_sha256":"f11fbc46aff09d73077a1cfd975e6042a9f18acceee1aa01a03aede4df3ece53","source":{"kind":"arxiv","id":"1801.01533","version":2},"attestation_state":"computed","paper":{"title":"Computational Analysis for the Rational Design of Anti-Amyloid Beta (ABeta) Antibodies","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.BM","authors_text":"D'Artagnan Greene, Jennifer Pan, Ray Luo, Tanya Tabibian, Theodora Po","submitted_at":"2018-01-04T20:11:54Z","abstract_excerpt":"Alzheimer's Disease (AD) is a neurodegenerative disorder that lacks effective treatment options. Anti-amyloid beta (ABeta) antibodies are the leading drug candidates to treat AD, but the results of clinical trials have been disappointing. Introducing rational mutations into anti-ABeta antibodies to increase their effectiveness is a way forward, but the path to take is unclear. In this study, we demonstrate the use of computational fragment-based docking and MMPBSA binding free energy calculations in the analysis of anti-ABeta antibodies for rational drug design efforts. Our fragment-based dock"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1801.01533","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-01-04T20:11:54Z","cross_cats_sorted":[],"title_canon_sha256":"615bd2627f2197fdb6084f4d35f5cf38dd9ecd5207ecd8a07d63a3cbd7f7ae02","abstract_canon_sha256":"45a4ae75a3c46ede345ed8f50e00331a419f3537291f108b0f023b3ad2aaaeb9"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:17:53.724405Z","signature_b64":"Bs7RpYE2OejmXhVNRRJxtvJz5CvJpUTgVMDvfzB95c+c1LnW/foBpVwFtrfQRoacUAGT8XHUIr7az/ervZeaAA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"f11fbc46aff09d73077a1cfd975e6042a9f18acceee1aa01a03aede4df3ece53","last_reissued_at":"2026-05-18T00:17:53.723767Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:17:53.723767Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Computational Analysis for the Rational Design of Anti-Amyloid Beta (ABeta) Antibodies","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.BM","authors_text":"D'Artagnan Greene, Jennifer Pan, Ray Luo, Tanya Tabibian, Theodora Po","submitted_at":"2018-01-04T20:11:54Z","abstract_excerpt":"Alzheimer's Disease (AD) is a neurodegenerative disorder that lacks effective treatment options. Anti-amyloid beta (ABeta) antibodies are the leading drug candidates to treat AD, but the results of clinical trials have been disappointing. Introducing rational mutations into anti-ABeta antibodies to increase their effectiveness is a way forward, but the path to take is unclear. In this study, we demonstrate the use of computational fragment-based docking and MMPBSA binding free energy calculations in the analysis of anti-ABeta antibodies for rational drug design efforts. Our fragment-based dock"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1801.01533","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1801.01533","created_at":"2026-05-18T00:17:53.723850+00:00"},{"alias_kind":"arxiv_version","alias_value":"1801.01533v2","created_at":"2026-05-18T00:17:53.723850+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1801.01533","created_at":"2026-05-18T00:17:53.723850+00:00"},{"alias_kind":"pith_short_12","alias_value":"6EP3YRVP6COX","created_at":"2026-05-18T12:32:08.215937+00:00"},{"alias_kind":"pith_short_16","alias_value":"6EP3YRVP6COXGB32","created_at":"2026-05-18T12:32:08.215937+00:00"},{"alias_kind":"pith_short_8","alias_value":"6EP3YRVP","created_at":"2026-05-18T12:32:08.215937+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK","json":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK.json","graph_json":"https://pith.science/api/pith-number/6EP3YRVP6COXGB32DT6ZOXTAIK/graph.json","events_json":"https://pith.science/api/pith-number/6EP3YRVP6COXGB32DT6ZOXTAIK/events.json","paper":"https://pith.science/paper/6EP3YRVP"},"agent_actions":{"view_html":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK","download_json":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK.json","view_paper":"https://pith.science/paper/6EP3YRVP","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1801.01533&json=true","fetch_graph":"https://pith.science/api/pith-number/6EP3YRVP6COXGB32DT6ZOXTAIK/graph.json","fetch_events":"https://pith.science/api/pith-number/6EP3YRVP6COXGB32DT6ZOXTAIK/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK/action/timestamp_anchor","attest_storage":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK/action/storage_attestation","attest_author":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK/action/author_attestation","sign_citation":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK/action/citation_signature","submit_replication":"https://pith.science/pith/6EP3YRVP6COXGB32DT6ZOXTAIK/action/replication_record"}},"created_at":"2026-05-18T00:17:53.723850+00:00","updated_at":"2026-05-18T00:17:53.723850+00:00"}